Nicholas Investments Partners »

Enliven Therapeutics shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 174k 25.54